WEREWOLF THERAPEUTICS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $152.8M | $157.5M |
| FY2022 | — | $122.3M | $129.3M |
| FY2023 | $40.0M | $111.4M | $134.3M |
| FY2024 | $32.1M | $73.4M | $111.0M |
| FY2025 | $32.1M | $24.8M | $57.1M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $152.8M | $157.5M |
| FY2022 | — | $122.3M | $129.3M |
| FY2023 | $40.0M | $111.4M | $134.3M |
| FY2024 | $32.1M | $73.4M | $111.0M |
| FY2025 | $32.1M | $24.8M | $57.1M |